orlistat semaglutide for Weight Loss Five drugs are now approved

In October 2017, following a unanimous FDA Advisory Committee approval, the injectable version (Ozempic) was approved for diabetes treatment in the US and later in other countries, including: Canada European Union Japan Australia The oral version (Rybelsus) received US approval in September 2019, with EU approval in April 2020

High cortisol can raise insulin and increase belly fat storage

Blood pressure and lipid improvements : Semaglutide reduced systolic blood pressure by 3.3 mm Hg and improved lipid profiles, all achieved on top of high baseline rates of evidence-based cardiovascular therapies (90% on statins, 86% on antiplatelet agents)

For patients requiring additional glycaemic control after at least four weeks at 0.5 mg, the dose may be increased to 1 mg once weekly

Nat Metab